Tinlarebant is a investigational new drug that is being evaluated to treat dry macular degeneration and Stargardt disease. It is a retinol binding protein 4 antagonist.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.